Cellf BIO Begins Phase I Clinical Trial of BioSphincter^™ Implant for Fecal Incontinence

Cellf BIO announced the beginning of its Phase I clinical trial for its BioSphincter™ Implant for the treatment of severe passive fecal incontinence. The FDA cleared the company’s Investigational New Drug application, and the Institutional Review Board approved the trial to begin enrolling participants.